Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Elizabeth, Ness"'
Autor:
Jessica M. Faupel-Badger, Amanda L. Vogel, Shadab F. Hussain, Christopher P. Austin, Matthew D. Hall, Elizabeth Ness, Philip Sanderson, Pramod S. Terse, Xin Xu, Krishna Balakrishnan, Samarjit Patnaik, Juan J. Marugan, Udo Rudloff, Marc Ferrer
Publikováno v:
Journal of Clinical and Translational Science, Vol 6 (2022)
There are numerous examples of translational science innovations addressing challenges in the translational process, accelerating progress along the translational spectrum, and generating solutions relevant to a wide range of human health needs. Exam
Externí odkaz:
https://doaj.org/article/d04c5654f35f49988876957604e51d81
Autor:
Elizabeth Ness
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 7, Iss 3, Pp 237-242 (2020)
Clinical research nursing is a specialty practice that has evolved over the past century. Clinical research nurses (CRNs) work directly (e.g., direct care provider and advance clinician) or indirectly (e.g., manager, educator, and study co-ordinator)
Externí odkaz:
https://doaj.org/article/1a3efb542a3949e2830abda00738c1d5
Autor:
Kathryn Finch Mileham, Cassadie Moravek, Andrew S. Kennedy, Thomas S. Uldrick, E. Claire Dees, Caroline Schenkel, Scot Ebbinghaus, S. Percy Ivy, Jamie Renee Brewer, Atiqur Rahman, R. Donald Harvey, Vishal Bhatnagar, Elizabeth Ness
Publikováno v:
Clin Cancer Res
Purpose: Washout periods and concomitant medication exclusions are common in cancer clinical trial protocols. These exclusion criteria are often applied inconsistently and without evidence to justify their use. The authors sought to determine how was
Publikováno v:
Oncology Clinical Trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aebca78916f8ad5104ad411ee3cbf4dc
https://doi.org/10.1891/9780826168733.0023
https://doi.org/10.1891/9780826168733.0023
Autor:
Ann M. O'Mara, Meredith A. Grady, Clare Hastings, Elizabeth Ness, Anne E. Belcher, Annette Galassi, Linda K. Parreco
Publikováno v:
Journal of Nursing Education. 53:466-472
The aim of this study was to understand the current environment around clinical research relating to nursing education and practice. This descriptive study analyzed data from 33 in-depth interviews with faculty members, nurse executives, staff develo
Autor:
Nelson, Elizabeth Ness
Publikováno v:
Humboldt Journal of Social Relations, 1977 Oct 01. 5(1), 90-117.
Externí odkaz:
https://www.jstor.org/stable/23261802
Publikováno v:
Contemporary clinical trials. 48
Understanding the human experience is no longer an outcome explored strictly by social and behavioral researchers. Increasingly, biomedical researchers are also including patient reported outcomes (PROs) in their clinical research studies not only du
Autor:
Kathleen M. Williams, Jeffrey S. Humphrey, Naiyer A. Rizvi, Delina A. Conway, Diana J. Daly, Elizabeth Ness, Michael D. Johnson, Daryl Sonnichsen, John Marshall, Elora Gupta, Herbert Hurwitz
Publikováno v:
Clinical Cancer Research. 10:1963-1970
Purpose: BMS-275291 is a novel broad-spectrum inhibitor of matrix metalloproteinase (MMPs) rationally designed to spare a class of closely related metalloproteinases known as sheddases. Inadvertent sheddase inhibition is hypothesized to play a role i
Autor:
Pankaj Bhargava, Elizabeth Ness, Naiyer Rizvi, Michael D. Johnson, Michael Oberst, Michael J. Hawkins, Brian M. Norris, Dorraya El-Ashry, Slawomir Wojtowicz-Praga, Yair Fuxman, Said Baidas, John L. Marshall, Neelesh Bangalore
Publikováno v:
Cancer Biology & Therapy. 1:409-416
Purpose: Bryostatin-1 is a compound known to inhibit protein kinase C expression. Clinical trials have focused on administration schedules ranging from 1 hour to 72 hour infusions. Preclinical data suggest that the down regulation of the target PKC o
Autor:
Jennifer Low, Elizabeth Ness, Michael J. Hawkins, Jeff Moore, James F. Barter, Alice Cole, John L. Marshall, Robert B. Dickson, Peter McCann, Mark Sale, Slawomir Wojtowicz-Praga
Publikováno v:
Investigational New Drugs. 14:193-202
Degradation of basement membrane and extracellular matrix by matrix metalloproteinases (MMPs) is believed to be required for tumor invasion, tumor-induced angiogenesis and vascular invasion. A synthetic hydroxamate, batimastat (also known as BB-94),